Pharmacological Characterization of a Primary Nicotinic Receptor from the Neuromuscular Junction
Speakers: Andrew Cook, Senior Study Director, Eurofins Discovery Services
Abstract:
Nicotinic acetylcholine receptors...
At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Fluxion delivers advanced solutions that transform complex cell-based and cell-free assays. Leading labs across the globe rely on Fluxion's instruments, kits, and lab services to research novel biology, accelerate drug discovery, and tailor therapies based on patient-specific biomarkers.
Application Notes
Recorded Webinars
Publications
Speakers: Andrew Cook, Senior Study Director, Eurofins Discovery Services
Abstract:
Nicotinic acetylcholine receptors...
Speaker: Dr. Andrew Jenkins Ph.D, Associate Professor, Faculty of Pharmacy & Pharmaceutical Sciences, Emory University...
Electrical voltage patterns...
Exciting New T Cell Therapies Present Unique Challenges in Drug Development.
Immunotherapeutics stimulate the...
As we go through our lives, we spend a third of that time sleeping. Although this time does not amass to anything...